"On January 28, 2025, President Donald Trump signed Executive Order No. 14187 (the “Healthcare Ban”), directing all federal agencies to “immediately take appropriate steps to ensure that institutions receiving Federal research or education grants end” gender-affirming medical care for people under nineteen, which as this brief describes is critical, medically necessary, evidence-based care for gender dysphoria. Effectively denying such evidence-based medical care to adolescents who meet the requisite medical criteria puts them at risk of significant harm. Below, amici provide the Court with an accurate description of the relevant treatment guidelines and summarize the scientific evidence supporting the gender-affirming medical care for adolescents that is targeted in the Healthcare Ban."
Read the Brief
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
